Navigation Links
Synovics Pharmaceuticals Announces the Appointment of Jyotindra Gange as Principal Executive Officer
Date:7/10/2008

s; market and customer acceptance and demand for its products; the Company's possible dependence on continued or future revenues from significant customers; the use of estimates in the preparation of the Company's financial statements; the potential for competitors to file ANDAs prior to any filing by the Company pertaining to the same target brand; the impact of competitive products and pricing on products, including the launch of authorized generics; the ability to launch new products in the timeframes it expects; the availability of raw materials or "APIs"; the availability of any product it may purchase; the regulatory environment; the Company's exposure to product liability and other lawsuits and contingencies; the increasing cost of insurance and the availability of product liability insurance coverage; the Company's timely and successful completion of strategic initiatives, including integrating companies and products it may acquire and implementing its Front-End India strategy; fluctuations in operating results, including the effects on such results from spending for research and development, sales and marketing activities and patent challenge activities; the inherent uncertainty associated with financial projections; the outcome of ongoing efforts to improve Kirks operational efficiency and customer performance; changes in generally accepted accounting principles, fluctuations in operating results; capital adequacy; statements of future plans relating to the Company's capital needs, product development and filings with the FDA, viability, application or continuation of the Company's business licenses including Drug, Enforcement and Administrations licenses for scheduled drugs; business and growth strategies; statements specifically concerning the successful closing of acquisitions, and satisfying closing conditions of any current or future financial transactions including debt or equity requirements, regulatory requirements; and meeting conditions set by po
'/>"/>
SOURCE Synovics Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Synovics Pharmaceuticals forms a Strategic Joint Venture with Maneesh Pharmaceuticals
2. Synovics Pharmaceuticals Files Its Second Quarter, 2008 Form 10Q with the SEC
3. Synovics Pharmaceuticals Announces Execution of Hormonal Manufacture and Supply Contract
4. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
8. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
9. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
10. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.
11. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... ... July 28, 2015 , ... ... with 1 in 68 children currently affected with the disorder. For these families, ... the road to recovery is extremely daunting. That’s where Talk About Curing Autism ...
(Date:7/28/2015)... ... ... Healthline , a provider of intelligent health information and technology solutions, ... digital health . The survey, which was conducted among 3,679 Healthline.com ... of trust in the security of digital health tools, impact of these tools on ...
(Date:7/28/2015)... , ... July 28, 2015 , ... Women in Technology ... D.C. technology community for over 20 years, has selected Lisa Dezzutti, CEO and president ... year. , “I am excited to serve this organization that empowers women to thrive ...
(Date:7/28/2015)... ... ... Master flutist and solo artist Gary Stroutsos shares his deep resume of ... of serene, restorative instrumental music. Tracks carefully curated by White Swan producer Dubgoddess ... more -- to help the listener deeply breathe in a healing inner light for ...
(Date:7/28/2015)... La Mirada, CA (PRWEB) , ... July 28, 2015 , ... ... XC, a collagen-filling injectable that returns skin to a smooth state, and reduces the ... XC is the “first and only FDA-approved injectable gel to instantly add volume to ...
Breaking Medicine News(10 mins):Health News:National TACA Autism Conference Offers Hope and Help to Families Affected by Autism 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 2Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 3Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 4Health News:Consumers Concerned About Privacy of Personal Health Data on Wearables and Mobile Apps, According to New Healthline Survey 5Health News:Lisa Dezzutti Named President of Women in Technology (WIT) Board of Directors 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 2Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 3Health News:Flute Meditations for Yoga & Massage: Calming Spa Music for Relaxation & Sleep by Gary Stroutsos 4Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 2Health News:Healthpointe’s Cosmetic Laser Institute Now Providing Juvéderm Voluma XC in Anaheim 3
... Legendary Green Bay Packers coach Vince Lombardi once said, "Winning ... small-market franchises seeking to increase their fan base, winning does ... well as the number of games played in prime time, ... Scott Tainsky, a professor of recreation, sport and tourism ...
... future, nurses may more accurately detect and alleviate symptoms ... five-year, $2.7-million grant from the National Institute of Nursing ... of nursing, Penn State, seeks to improve nurses, assessment ... delirium and dementia. Delirium and dementia have similar ...
... Reinberg HealthDay Reporter , TUESDAY, Aug. 3 (HealthDay ... lower their homocysteine levels may not be protected from second ... Earlier studies found an association between homocysteine, an amino acid, ... heart attack. Vitamin B supplements lower homocysteine levels, but whether ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, Aug. 3 ... as young as 1 month old, a new study shows. ... a lack of eye contact or smiling, the researchers noted. ... later diagnosed with an autism spectrum disorder were more likely to ...
... physician and chemical manufacturer groups, today announced support for ... and Drug Administration (FDA) much-needed authorities to better protect ... a joint letter to Congress and during an audio ... introduce this drug safety legislation. Consumers face a ...
... A major breakthrough in how to target and ... has been made by researchers at Wake Forest University ... way to target and destroy Glioblastoma multiforme (GBM) cells ... new possibilities in cancer research previously not known to ...
Cached Medicine News:Health News:Winning record, team longevity, prime-time games influence NFL TV ratings 2Health News:Winning record, team longevity, prime-time games influence NFL TV ratings 3Health News:Winning record, team longevity, prime-time games influence NFL TV ratings 4Health News:Nurses will test method for determining if it's dementia or delirium 2Health News:Vitamin B May Not Guard Against Second Stroke, Heart Attack 2Health News:Vitamin B May Not Guard Against Second Stroke, Heart Attack 3Health News:Signs of Autism May Show in Early Infancy 2Health News:Signs of Autism May Show in Early Infancy 3Health News:Consumer and manufacturing groups back bill to protect US drug supply 2Health News:Consumer and manufacturing groups back bill to protect US drug supply 3Health News:Scientists develop 'designer protein,' opening new door in cancer research 2Health News:Scientists develop 'designer protein,' opening new door in cancer research 3
(Date:7/28/2015)... Calif. , July 28, 2015  Leaf ... burden that pressure ulcers place on the healthcare ... a leading threat to modern quality healthcare. Research ... Services, Agency for Healthcare Research and Quality shows ... more than $11 billion a year. The condition ...
(Date:7/28/2015)... --  Cynosure, Inc. (Nasdaq: CYNO ), ... aesthetic procedures and precision surgical applications worldwide, today ... June 30, 2015. "Our North American ... revenues increased 47 percent year-over-year and selling prices ... Davin. "While our international results reflected the economic ...
(Date:7/28/2015)... 2015  CryoLife, Inc. (NYSE: CRY ), a ... cardiac and vascular surgery, announced today its results for ... Pat Mackin, Chairman, President and Chief ... execute on our growth strategy with solid progress on ... announced plans to transition to a direct sales model ...
Breaking Medicine Technology:Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 2Impact of Pressure Ulcers on Patient Care: Leaf Healthcare Releases White Paper on the Healthcare Burden of Pressure Ulcers 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 2Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 3Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 4Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 5Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 6Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 7Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 8Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 9Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 10Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 11Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 12Cynosure Announces Second-Quarter 2015 Results; Record Revenue of $83.7 Million, Up 15 Percent from Prior Year 13CryoLife Reports Second Quarter Financial Results 2CryoLife Reports Second Quarter Financial Results 3CryoLife Reports Second Quarter Financial Results 4CryoLife Reports Second Quarter Financial Results 5CryoLife Reports Second Quarter Financial Results 6CryoLife Reports Second Quarter Financial Results 7CryoLife Reports Second Quarter Financial Results 8CryoLife Reports Second Quarter Financial Results 9CryoLife Reports Second Quarter Financial Results 10CryoLife Reports Second Quarter Financial Results 11CryoLife Reports Second Quarter Financial Results 12CryoLife Reports Second Quarter Financial Results 13CryoLife Reports Second Quarter Financial Results 14
... Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE ... clinical sample from a US patient.  This follows ... under the US Clinical Laboratories Improvements Amendments (CLIA) (42 ... Phenogen Sciences, the Company,s new North American subsidiary, where ...
... May 31, 2011 WaferGen Biosystems, Inc. (OTCBB: WGBS), ... announced it has closed its previously announced private placement ... life science investors, Great Point Partners, LLC, Deerfield Management ... and management.  The final transaction size was $30.6 million. ...
Cached Medicine Technology:Genetic Technologies Processes First BREVAGen™ Patient Sample 2Genetic Technologies Processes First BREVAGen™ Patient Sample 3WaferGen Closes $30 Million Financing with Three Leading Life Science Institutional Investors 2WaferGen Closes $30 Million Financing with Three Leading Life Science Institutional Investors 3WaferGen Closes $30 Million Financing with Three Leading Life Science Institutional Investors 4
Used following open gallbladder procedure to drain bile. Often attached to Bard bile bag....
Hubbed drains are made of translucent silicone and include a full-length X-ray opaque stripe....
... Greater Patient Comfort than chest tubes and ... silicone drains with four channels along the ... other components consist of a silicone hub, ... The drains are available either 3/4 fluted ...
Used for serial post-operative cholangiography and the placement of a wire guide to facilitate post-operative E.R.C.P. Supplied sterile in peel-open packages. Intended for one-time use....
Medicine Products: